74272-78-9

Basic information

• Product Name: Benzoic acid, 2,3-bis(phenylmethoxy)-
• CAS NO: 74272-78-9
• Molecular Formula: C21H18O4
• Molecular Weight: 334.372
• Mol File: 74272-78-9.mol
• Article Data: 46

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2,3-bis(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2,3-bis(phenylmethoxy)-(74272-78-9)
• EPA Substance Registry System: Benzoic acid, 2,3-bis(phenylmethoxy)-(74272-78-9)

Safety Data

• Hazardous Substances Data: 74272-78-9(Hazardous Substances Data)

Upstream product

• 24677-78-9 2,3-dihydroxybenzaldehyde 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 95922-26-2 benzyl 2,3-bis(benzyloxy)benzoate 
• 303-38-8 2,3-Dihydroxybenzoic acid 
• 2411-83-8 methyl-2,3-dihydroxybenzoate 
• 2169-27-9 Methyl 2,3-bis(benzyloxy)benzoate 
• 5779-91-9 2,3-bis(benzyloxy)benzaldehyde 

Downstream Products

• 81254-86-6 2,3-bis(benzyloxy)-1-((2-thioxothiazolidin-1-yl)carbonyl)benzene 
• 141210-61-9 N¹,N⁸-bis(2,3-dibenzyloxybenzoyl)-N⁴-(4-nitrobenzyloxycarbonyl)-spermidine 
• 69146-58-3 2,3-bis(benzyloxy)benzoyl chloride 
• 74272-81-4 2,3-bis(benzyloxy)-N-(3-(4-(2,3-bis(benzyloxy)benzamido)butylamino)propyl)benzamide 
• 167275-82-3 (3R,4S)-4-Benzyloxycarbonylamino-8-(2,3-bis-benzyloxy-benzoylamino)-3-hydroxy-octanoic acid ethyl ester 
• 171667-83-7 C₇₁H₆₈N₄O₁₀ 
• 192802-99-6 N-(aminobutyl)-2,3-bis(benzyloxy)benzamide 
• 95245-16-2 N¹,N⁷-bis[2,3-bis(benzyloxy)benzoyl]norspermidine 
• 705281-82-9 2,3-bis(benzyloxy)-N-(3-hydroxypropyl)benzamide 
• 909704-13-8 formylmethyl 2,3-dibenzyloxybenzoate 
• 909704-32-1 N-formylmethyl 2,3-dibenzyloxybenzamide 
• 909704-41-2 N-(2',2'-dimethoxyethyl) 2,3-dibenzyloxybenzamide 
• 909704-40-1 2',2'-diethoxyethyl 2,3-dibenzyloxybenzoate 

Relevant articles and documents

Nanomechanics of Anion-πInteraction in Aqueous Solution

Noncovalent interactions play a constitutive role in numerous biological processes, including biomolecular adhesion, recognition, and transport. Unlike π-πand cation-πinteractions, anion-πinteraction was only recently and computationally recognized to par

CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES

The present invention relates to conjugates comprising one or more compounds selected from of (i) an anti-inflammatory compound, and/or (ii) an antioxidant compound, and/or (iii) and antibiotic compound and/or, (iv) a metal chelating compound and at least

PEPTOID-BASED CHELATING LIGANDS FOR SELECTIVE METAL CHELATION

The present disclosure provides peptoid-based chelating ligands, corresponding cyclic peptoids, and methods of making thereof. Functional groups may be tailored for high metal binding affinity and selectivity. The side chains of a cyclic peptoid according to the present disclosure may be selected based on, for example, high affinity for actinide or other metal ions, selectivity for actinide or other metal ions, the ability to recover a metal once it is bound to the peptoid, and whether the overall peptoid should be hydrophobic or hydrophilic. Unlike siderophores, peptoid-based chelating ligands of the present disclosure are not readily hydrolyzed under physiological conditions. Therefore, peptoid-based chelating ligands may be, for example, used to treat actinide (e.g., iron and lead) poisoning in vivo. Moreover, peptoid-based chelating ligands of the present disclosure may be used for medical imaging, chelation therapy, drug delivery, and separation technologies, for example.